Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market

Go back to Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market
(NASDAQ: INBS) Delayed: 1.95 -0.05 (2.5%)
Previous Close $2.00    52 Week High
Open $2.00    52 Week Low
Day High $2.00    P/E N/A 
Day Low $1.90    EPS
Volume 35,380       

(NASDAQ: INBS) Delayed: 1.95 -0.05 (2.5%)
Previous Close $2.00    52 Week High
Open $2.00    52 Week Low
Day High $2.00    P/E N/A 
Day Low $1.90    EPS
Volume 35,380